Company Filing History:
Years Active: 2015-2024
Title: Bettina Wanko: Innovator in Antibody Sequestration
Introduction
Bettina Wanko is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of compounds for the sequestration of undesirable antibodies. With a total of four patents to her name, her work addresses critical challenges related to autoimmune diseases.
Latest Patents
Wanko's latest patents focus on a compound designed for the sequestration of undesirable antibodies in patients. This innovative compound includes an inert biopolymer scaffold and at least two peptide n-mers, each defined by the general formula P(—S—P). The peptides consist of sequences ranging from 2 to 13 amino acids, with a non-peptide spacer. The patents also detail pharmaceutical compositions that incorporate this compound, along with methods for sequestering antibodies and inhibiting immune reactions to active agents.
Career Highlights
Throughout her career, Bettina Wanko has worked with notable companies such as Affiris AG and Ablevia Biotech GmbH. Her experience in these organizations has allowed her to refine her expertise in biotechnology and patent development.
Collaborations
Wanko has collaborated with several professionals in her field, including Sylvia Brunner and Gergana Galabova. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Bettina Wanko's work in antibody sequestration represents a significant advancement in biotechnology. Her patents and collaborations highlight her commitment to addressing autoimmune diseases through innovative solutions.